Publication | Closed Access

Cytotoxic, mutagenic and genotoxic effects of new anti-T. cruzi 5-phenylethenylbenzofuroxans. Contribution of phase I metabolites on the mutagenicity induction

BiochemistryMedicineSecondary MetaboliteToxicologyGenotoxic EffectsAnti-cancer AgentExperimental ToxicologyPharmacologyMutagenicity InductionToxicological MechanismDrug DiscoveryToxicogenomics